Back
Cellectar Biosciences Stock Price Chart
Sponsored
CLRB
Sponsored
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
25
CLRB
Cellectar Biosciences
Last Price:
$0.28
Seasonality Move:
-3.55%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.
Cellectar Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.32 | Sell |
20-day SMA: | 0.29 | Sell |
50-day SMA: | 1.17 | Sell |
200-day SMA: | 2.28 | Sell |
8-day EMA: | 0.32 | Sell |
20-day EMA: | 0.47 | Sell |
50-day EMA: | 0.98 | Sell |
200-day EMA: | 1.96 | Sell |
Cellectar Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 19.59 | Sell |
Chaikin Money Flow: | -676885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.07 - 0.93) | Sell |
Bollinger Bands (100): | (0.92 - 2.34) | Sell |
Cellectar Biosciences Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day simple moving average is 0.32, which is a Sell signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day SMA is 0.29, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 1.17 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 2.28, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
25
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.28. The Score for CLRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
11.7M
Price in USD:
0.28
Share Volume:
1.6M
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
0.22
Sell
25
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.28 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.28 while CLRB 8-day exponential moving average is 0.32, which is a Sell signal.
-
The stock price of CLRB is 0.28 while Cellectar Biosciences 20-day EMA is 0.47, which makes it a Sell.
-
Cellectar Biosciences 50-day exponential moving average is 0.98 while CLRB share price is 0.28, making it a Sell technically.
-
CLRB stock price is 0.28 and Cellectar Biosciences 200-day simple moving average is 1.96, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and a decrease next year of $0.29 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Cellectar Biosciences is a Sell
-
Cellectar Biosciences Relative Strength Index (RSI) is 19.59, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.07 - 0.93), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (0.92 - 2.34), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.